A method for in vitro prediction of the glycemic index of oat products

By constructing a GI prediction model for oat products based on digital twins and machine learning, and integrating multi-dimensional data, the problem of inaccurate prediction in existing technologies has been solved, achieving high-precision and efficient GI prediction, and possessing the potential for industrial application.

CN122369688APending Publication Date: 2026-07-10JIANGNAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610402506.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-03-30
Publication Date
2026-07-10

AI Technical Summary

Technical Problem

Existing technologies struggle to quickly and accurately predict the glycemic index of oat products, and existing models fail to effectively integrate key factors such as starch structure and physical form during processing, resulting in limited predictive universality and stability.

Method used

A GI prediction model for oat products based on the fusion of digital twin and machine learning was established. By integrating the nutritional components, structural characteristics and in vitro digestion parameters of raw materials, a nonlinear fitting equation was constructed, and GI prediction was performed using β-glucan content, damaged starch content, median particle size, aleurone layer thickness and 180 min hydrolysis index.

Benefits of technology

It achieves high-precision and high-efficiency GI prediction, with a determination coefficient R² of 0.91 and a mean absolute error (MAE) of only 1.57. It provides a fast and low-cost in vitro prediction tool and has clear industrial application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122369688A_ABST
    Figure CN122369688A_ABST
Patent Text Reader

Abstract

This invention discloses a method for predicting the glycemic index (GI) of oat products in vitro, belonging to the field of food testing technology. This invention systematically integrates multi-dimensional data on the nutritional components, structural characteristics, and in vitro digestion kinetics of oat products. Using machine learning algorithms such as Bayesian ridge regression, it screens out five key predictive factors: β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and 180-minute hydrolysis index. Combined with in vivo GI measurements, a high-precision prediction model is constructed through nonlinear regression fitting. This invention transforms the complex GI formation mechanism into a clear and measurable quantitative relationship, providing an efficient and low-cost technical solution for the rapid development, process optimization, and quality control of low-GI oat products, and has clear industrial application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a method for predicting the glycemic index of oat products in vitro, belonging to the field of food testing technology. Background Technology

[0002] Elevated postprandial blood glucose is closely associated with oxidative stress and subclinical inflammation, and is a significant contributing factor to chronic diseases such as type 2 diabetes, cardiovascular disease, and obesity. Therefore, controlling postprandial blood glucose fluctuations is crucial for reducing the risk of these diseases. Against this backdrop, dietary interventions (particularly through the intake of whole grains and regulation of starch digestion) have become a core strategy for managing glycemic response. Oats, as a representative of whole grains, have advantages in protein and lipid content and are rich in β-glucan, which has significant thickening and gastric emptying-delaying effects. Oat products generally have a lower glycemic response than most other types of ready-to-eat cereals, making them an ideal raw material for the development of low-glycemic-response foods.

[0003] Currently, while the main in vivo methods for predicting the glycemic index (GI) of foods are considered the "gold standard," they are still limited by inherent drawbacks such as large individual variability in response, high cost, and long cycle time, making them difficult to apply to rapid screening and formulation optimization in food research and development. Animal models, on the other hand, are difficult to use widely due to ethical controversies and high costs (In vitro and animal models to predict the glycemic index value of carbohydrate-containing foods[J].Trendsin Food Science & Technology, 2022.).

[0004] Oats are widely recognized as a low glycemic index (GI) food, but this doesn't mean that all oat preparation methods maintain low GI properties. Even uncooked oats generally have a higher GI value the more refined the processing. Whole oat rice has a GI value of about 42 (low GI), conventionally pressed oat flakes about 59 (medium GI), and instant oat flakes can be as high as 83 (high GI). Furthermore, extending the cooking time increases the GI value; oat rice cooked at atmospheric pressure for 80 minutes has a significantly higher GI value (62) than oat rice cooked for only 18 minutes (59).

[0005] Existing research on in vitro oat glycemic index (GI) prediction mainly follows three technical paths, but all have significant limitations. Early studies primarily established empirical associations between single nutrients such as β-glucan or total dietary fiber and GI. These models neglect changes in key factors such as starch structure and physical form during processing, resulting in poor predictive universality (Harnessing in vitro digestion of commercial oats for predicting their glycemic index (GI)[J]. European food research and technology, 2023.). Parametric models based on in vitro digestion kinetics are simple to operate, low in cost, and highly efficient. However, most of these models rely only on digestion endpoint parameters and fail to integrate key upstream structural factors affecting digestion rates, resulting in limited predictive stability for products processed by different methods. In recent years, some studies have attempted to apply machine learning algorithms to handle more complex datasets. However, these methods often face the "black box" problem, making it difficult for model predictions to guide production process control.

[0006] Therefore, developing a GI prediction model for oat products based on multi-dimensional features and artificial intelligence algorithms to achieve rapid and accurate evaluation is of great significance for promoting the research and development of personalized nutrition and low-GI foods. Summary of the Invention

[0007] To address the aforementioned issues, this invention establishes a GI prediction model for oat products based on the fusion of digital twins and machine learning. This invention integrates multidimensional data such as raw material nutrient components, structural characteristics, and in vitro digestion parameters, and performs correlation analysis with in vivo measured GI values. This enables intelligent screening and nonlinear fitting of key predictive factors, thereby constructing a highly accurate GI prediction model.

[0008] The first objective of this invention is to provide a method for predicting the glycemic index of oat products in vitro. This method involves substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and 180-minute hydrolysis index of the oat product into an equation to calculate the glycemic index. The equation is as follows: GI=0.00035 × β-GL × DS × MP × AL × (HI-180) 2 +30.96 Wherein, GI value is the glycemic index of the oat being tested; β-GL is the β-glucan content of the oat being tested (g / 100g); DS is the damaged starch content of the oat being tested (%); MP is the median particle size of the oat being tested (μm); AL is the aleurone layer thickness of the oat being tested (μm); and HI-180 is the hydrolysis index of the oat being tested after 180 min of in vitro digestion (%).

[0009] In one embodiment, the β-glucan content was determined using the enzymatic method according to GB 5009.289-2023; the damaged starch content was determined according to AACC Method 76-31.01, the American Association of Cereal Chemists' standard, "Determination of Damaged Starch (Maltose Method)"; the median particle size was determined according to the laser diffraction method according to ISO 13320:2020; the aleurone layer thickness was observed according to NY / T 2334-2013, "Methods for Identifying the Structure and Morphology of Cereal Grains"; and the starch hydrolysis index from 0 to 180 minutes was determined based on an in vitro simulated digestion experiment.

[0010] In one embodiment, the starch digestion and hydrolysis index for 0-180 min is determined by the Englyst in vitro simulated digestion method.

[0011] In one embodiment, the oat product sample to be tested includes one or more of the following: oats, oat bran, oat flour, mixed oats, etc.

[0012] In one embodiment, the oat product to be tested may be either uncooked or cooked.

[0013] In one embodiment, cooking includes boiling the oat product to be tested in boiling water (100°C) or brewing the oat product to be tested.

[0014] A second objective of this invention is to provide a device for predicting the glycemic index of oat products in vitro, the device comprising a nutrient composition determination module, a structural feature detection module, and an in vitro simulated digestion module; The nutrient composition determination module measures the β-glucan, starch, damaged starch, available carbohydrates, protein, lipids, dietary fiber, moisture, and ash content of the oat product being tested. The structural feature detection module measures the aleurone layer thickness, median particle size, starch crystal type, and protein network structure of the oat product under test. The in vitro simulated digestion module was used to determine the glucose release, hydrolysis index, area under the starch hydrolysis curve, reaction rate constant, theoretical maximum hydrolysis rate, and hemihydrolysis time of the oat product under test. The device calculates the glycemic index by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and 180-minute hydrolysis index of the oat product under test into an equation; the equation is: GI=0.00035 × β-GL × DS × MP × AL × (HI-180) 2 +30.96 Wherein, GI value is the glycemic index of the oat being tested; β-GL is the β-glucan content of the oat being tested (g / 100g); DS is the damaged starch content of the oat being tested (%); MP is the median particle size of the oat being tested (μm); AL is the aleurone layer thickness of the oat being tested (μm); and HI-180 is the hydrolysis index of the oat being tested at 180 min (%).

[0015] In one embodiment, the sample of the flour product to be tested includes one or more of the following: oats, oat bran, oat flour, mixed oats, etc.

[0016] A third object of the present invention is to provide the application of any of the described devices in determining the GI value of oat products.

[0017] The fourth objective of this invention is to provide a method for improving the accuracy of in vitro prediction of the glycemic index (GI) of oat products. This method involves substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and hydrolysis index at 180 min of the oat product into an equation to calculate the glycemic index. The equation is as follows: GI=0.00035 × β-GL × DS × MP × AL × (HI-180) 2 +30.96 Wherein, GI value is the glycemic index of the oat being tested; β-GL is the β-glucan content of the oat being tested (g / 100g); DS is the damaged starch content of the oat being tested (%); MP is the median particle size of the oat being tested (μm); AL is the aleurone layer thickness of the oat being tested (μm); and HI-180 is the hydrolysis index of the oat being tested after 180 min of in vitro digestion (%).

[0018] In one embodiment, the β-glucan content was determined using the enzymatic method according to GB 5009.289-2023; the damaged starch content was determined according to AACC Method 76-31.01, the American Association of Cereal Chemists standard, "Determination of Damaged Starch (Maltose Method)"; the median particle size was determined according to the laser diffraction method according to ISO 13320:2020; the aleurone layer thickness was observed according to NY / T 2334-2013, "Methods for Identifying the Structure and Morphology of Cereal Grains"; and the starch hydrolysis index from 0 to 180 minutes was determined based on an in vitro simulated digestion experiment. The method for detecting the starch digestion and hydrolysis index from 0 to 180 min was the Englyst in vitro simulated digestion method.

[0019] In one embodiment, the sample of the flour product to be tested includes one or more of the following: oats, oat bran, oat flour, mixed oats, etc.

[0020] Beneficial effects of the present invention (1) A multi-dimensional, mechanism-driven comprehensive prediction model was innovatively constructed: For the first time, the nutritional components (β-glucan, damaged starch), physical structure (median particle size, aleurone layer thickness) and dynamic digestion parameters (HI-180) were systematically integrated into a nonlinear equation, which surpassed the traditional single index model and more scientifically revealed the "food matrix effect" that affects GI.

[0021] (2) It achieves high-precision and high-efficiency prediction performance: the model's coefficient of determination (R²) reaches 0.91, and the mean absolute error (MAE) is only 1.57. Its nonlinear form can accurately characterize the complex relationship between factors, and only requires 5 core indicators, achieving the optimal balance between prediction accuracy and ease of operation.

[0022] (3) It has clear industrial application value: It provides a rapid and low-cost in vitro prediction tool for the research and development of low-GI products, which can replace expensive human trials. All input variables are benchmarked against authoritative international and domestic testing standards, ensuring the reliability and repeatability of the results, which can be directly used to guide the optimization of formulations and the precise control of production processes. Attached Figure Description

[0023] Figure 1 The states of different oat products before and after steaming / cooking.

[0024] Figure 2 The in vitro digestion curves of different oat products are shown.

[0025] Figure 3 This study compares the GI values ​​of oat products predicted by a mathematical model with clinical GI values. Detailed Implementation

[0026] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention.

[0027] Test method: Damaged starch content was determined according to AACC Method 76-31.01, the American Association of Cereal Chemists standard, "Determination of Damaged Starch (Maltose Method)"; β-glucan content was determined using the enzymatic method according to GB 5009.289-2023.

[0028] Structural characteristics characterization: median particle size was determined by laser diffraction according to ISO 13320:2020; aleurone layer thickness was observed according to NY / T 2334-2013 "Methods for Identification of Grain Structure and Morphology".

[0029] HI-180 was determined using the Englyst in vitro simulated digestion method. The specific method involved accurately weighing approximately 100 mg (dry basis) of cooked oat products into a centrifuge tube, adding glass beads, deionized water, and sodium acetate buffer (0.2 M, pH 5.4, containing 4 mM calcium chloride), and vortexing to simulate physical disruption. Subsequently, a mixture of α-amylase (150 U / ml) and amyloglucosidase (3 U / ml) was added, and the mixture was placed in a shaker at 37 ℃ for 180 min to simulate the small intestinal digestive environment. Samples were taken precisely at 0, 5, 10, 15, 20, 30, 45, 60, 90, 120, and 180 minutes after the start of the reaction. The enzyme reaction was immediately inactivated with 9 volumes of anhydrous ethanol, and the supernatant was collected after centrifugation. The reducing sugar content at 540 nm wavelength was determined using the DNS method, digestion kinetic curves were plotted, the area under the curve was calculated, and the starch hydrolysis index was further calculated.

[0030] Clinical GI values ​​were obtained according to ISO 26642:2010.

[0031] Other nutrient component determinations: Protein content was determined according to GB 5009.5-2016 Kjeldahl method; Fat content was determined according to GB 5009.6-2016 Soxhlet extraction method; Dietary fiber content was determined according to GB 5009.88-2023 (soluble / insoluble dietary fiber) enzyme gravimetric method; Total starch content was determined according to GB 5009.9-2016 enzyme hydrolysis method; Amylose content was determined according to GB / T 15683-2008 method; Moisture content was determined according to GB 5009.3-2016 direct drying method; Ash content was determined according to GB 5009.4-2016 "National Food Safety Standard - Determination of Ash in Food"; β-glucan dissolution rate = amount dissolved in digestive juice after in vitro simulated digestion / total sample content; Protein dissolution rate = amount dissolved in digestive juice after in vitro simulated digestion / total sample content.

[0032] Example 1: A method for predicting the glycemic index of oat products in vitro 1. Fitting equation Based on the MATLAB R2021b platform, an in vitro prediction formula for the glycemic index of oat products was constructed.

[0033] Based on in vitro detection data of oat product samples and their corresponding in vivo glycemic index (GI) values, an initial modeling dataset was constructed. Missing value imputation and outlier identification and handling were performed on the dataset, and training and validation sets were created. On the training set, Bayesian ridge regression was used to select five key predictor variables—β-GL, DS, MP, AL, and HI-180—from multi-dimensional candidate indicators.

[0034] Subsequently, a simplified GI function expression was constructed based on key variables. Nonlinear least squares regression was then used to minimize the error between the predicted GI in the training set and the measured GI in vivo to determine the model coefficients and constant terms, forming the final, fixed prediction equation. R², RMSE, and MAE were calculated using an independent validation set, and the consistency between the predicted GI and the in vivo GI was evaluated using the LOOCV model. The equations are as follows: GI=0.00035 × β-GL × DS × MP × AL × (HI-180) 2 +30.96 Wherein, GI value is the glycemic index of the oat being tested; β-GL is the β-glucan content of the oat being tested (g / 100g); DS is the damaged starch content of the oat being tested (%); MP is the median particle size of the oat being tested (μm); AL is the aleurone layer thickness of the oat being tested (μm); and HI-180 is the hydrolysis index of the oat being tested at 180 min (%).

[0035] 2. Detect the GI value of oat products prepared using different methods. (1) Mixed oatmeal Commercially available mixed oat flakes (Suigeshi) were selected. The mixed oat flakes were steeped in boiling water for 4 min. 100 mg of the cooked sample (dry basis) was taken and its β-glucan content, damaged starch content, median particle size, aleurone layer thickness and hydrolysis index at 180 min were determined.

[0036] The GI value was calculated by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and hydrolysis index at 180 min into the equation.

[0037] (2) Oat flour Commercially available oat flour samples (Maijiamai) were selected. The oat flour was boiled in boiling water for 4 minutes and drained. 100 mg of the cooked sample (dry basis) was taken and its β-glucan content, damaged starch content, median particle size, aleurone layer thickness and hydrolysis index at 180 min were determined.

[0038] The GI value was calculated by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and hydrolysis index at 180 min into the equation.

[0039] (3) Oat bran Commercially available oat bran samples (Ximai) were selected. The oat bran was steeped in boiling water for 4 minutes. 100 mg of the cooked sample (dry basis) was taken, and its β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and hydrolysis index at 180 min were determined.

[0040] The GI value was calculated by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and hydrolysis index at 180 min into the equation.

[0041] (4) Steel-cut oats Commercially available steel-cut oat samples (Sai ​​staple food) were selected. The steel-cut oats were boiled in boiling water for 4 minutes, and 100 mg of the cooked sample (dry basis) was taken. The β-glucan content, damaged starch content, median particle size, aleurone layer thickness and hydrolysis index at 180 min were determined.

[0042] The GI value was calculated by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and hydrolysis index at 180 min into the equation.

[0043] 3. Results Statistics The different oat products selected in section 2, before and after cooking, are as follows: Figure 1 As shown.

[0044] The nutritional composition of different oat products is shown in Table 1; the structural characteristic parameters of different oat products are shown in Table 2; the in vitro digestion parameters of different oat products are shown in Table 3; and the in vitro digestion curves are shown in Table 4. Figure 2 As shown in Table 4; the area under the curve (AUC) of starch digestion for different oat products is shown in Table 5; the starch hydrolysis index (HI) of different oat products is shown in Table 6; the predicted GI and clinical GI values ​​of different oat products are also shown in Table 5. Figure 3 As shown in Table 6.

[0045] Table 1 Nutritional components

[0046] Table 2 Structural Features

[0047] Table 3 In vitro digestion parameters

[0048] Table 4. Area Under the Starch Digestion Curve (AUC)

[0049] Table 5 Starch Hydrolysis Index (HI)

[0050] Table 6 GI Predicted Values ​​and Clinical Values

[0051] As can be seen, based on the differences in raw materials and structural characteristics of different oat products, high-precision GI value prediction was achieved. As shown in Tables 1 and 2, oat bran has the highest β-glucan content (7.79 g / 100 g) and the most unique structure (aleurone layer thickness of 9.6 μm, area ratio of 84.8%); steel-cut oats have the largest median particle size (941.5 μm) and strong physical barrier; while oat flour has the highest damaged starch content (15.3%), indicating that it is more easily digested. In vitro digestion experiments (Tables 3-5) Figure 2 This directly confirms the above differences: oat flour has the slowest digestion rate and the lowest HI-180 value (0.28), which corresponds perfectly to the lowest clinical GI value (32). The relative errors between the model-predicted GI values ​​and the clinical values ​​are all within 2.5% (Table 6, ). Figure 3 This fully demonstrates that it can accurately quantify the digestibility characteristics determined by differences in raw materials, structure and processing, and convert them into reliable GI prediction values, exhibiting excellent accuracy and robustness.

[0052] In summary, Example 1, through multidimensional parameter screening, identified β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and 180-minute hydrolysis index as the core influencing factors, and constructed a high-precision nonlinear GI prediction model. Verification showed that this model exhibited good applicability and stability for oat products of different types and processing techniques, with a prediction error rate of less than 5%. This invention provides reliable technical support for the targeted research and development, raw material screening, formula optimization, and precise control of production processes for low-GI oat products, and possesses significant potential for industrial application.

[0053] Comparative Example 1: Constructing equations using different factors The glycemic index was calculated by substituting the median particle size and β-glucan dissolution rate of the oat product into the equation; the equation is as follows: GI = 56.02-0.024 × MP-0.38 × β-DR Wherein, GI value is the glycemic index of the oat sample, MP is the median particle size (μm) of the oat sample, and β-DR is the β-glucan dissolution rate (%) of the oat sample. 2 =0.72, MAE=18.16. The model prediction results are shown in Table 7.

[0054] Table 7. GI values ​​of oat products predicted based on a binary linear regression model.

[0055] Comparative Example 2: Constructing Equations Using Different Factors The glycemic index was calculated by substituting the median particle size and β-glucan dissolution rate of the oat product into the equation; the equation is as follows: GI = 55.02-0.028 × MP-0.55 × β-DR + 0.0009 × MP × β-DR Wherein, GI value is the glycemic index of the oat being tested, MP is the median particle size (μm) of the oat being tested, β-DR is the β-glucan dissolution rate (%) of the oat being tested, and R is the glycemic index of the oat being tested. 2 =0.82, MAE=7.99. The model prediction results are shown in Table 8.

[0056] Table 8. GI values ​​of oat products predicted based on a binary nonlinear regression model.

[0057] Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Any person skilled in the art can make various modifications and alterations without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be determined by the claims.

Claims

1. A method for predicting the glycemic index of oat products in vitro, characterized in that, The glycemic index was calculated by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and hydrolysis index at 180 min after in vitro digestion of the oat product into the equation; the equation is as follows: GI=0.00035 × β-GL × DS × MP × AL × (HI-180) 2 +30.96 Wherein, β-GL is the β-glucan content of the oat to be tested (g / 100g), DS is the damaged starch content of the oat to be tested (%), MP is the median particle size of the oat to be tested (μm), AL is the aleurone layer thickness of the oat to be tested (μm), and HI-180 is the hydrolysis index of the oat to be tested after 180 min of in vitro digestion (%).

2. The method according to claim 1, characterized in that, β-glucan content was determined by enzymatic method according to GB 5009.289-2023; damaged starch content was determined according to AACC Method 76-31.01, American Association of Cereal Chemists standard, "Determination of Damaged Starch (Maltose Method)"; median particle size was determined by laser diffraction according to ISO 13320:2020; aleurone layer thickness was observed according to NY / T 2334-2013, "Methods for Identification of Grain Structure and Morphology"; starch hydrolysis index from 0 to 180 minutes was determined based on in vitro simulated digestion experiments.

3. The method according to claim 2, characterized in that, The method for detecting the starch digestion and hydrolysis index from 0 to 180 min was the Englyst in vitro simulated digestion method.

4. The method according to claim 1, characterized in that, The oat products include one or more of oats, oat bran, oat flour, and mixed oats.

5. A device for predicting the glycemic index of oat products in vitro, characterized in that, The device includes a nutrient component determination module, a structural feature detection module, and an in vitro simulated digestion module. The nutrient composition determination module measures the β-glucan, starch, damaged starch, available carbohydrates, protein, lipids, dietary fiber, moisture, and ash content of the oat product being tested. The structural feature detection module measures the aleurone layer thickness, median particle size, starch crystal type, and protein network structure of the oat product under test. The in vitro simulated digestion module was used to determine the glucose release, hydrolysis index, area under the starch hydrolysis curve, reaction rate constant, theoretical maximum hydrolysis rate, and hemihydrolysis time of the oat product under test. The device calculates the glycemic index by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and 180-minute hydrolysis index of the oat product under test into an equation; the equation is: GI=0.00035 × β-GL × DS × MP × AL × (HI-180) 2 +30.96 Wherein, β-GL is the β-glucan content of the oat to be tested (g / 100g), DS is the damaged starch content of the oat to be tested (%), MP is the median particle size of the oat to be tested (μm), AL is the aleurone layer thickness of the oat to be tested (μm), and HI-180 is the hydrolysis index of the oat to be tested after 180 min of in vitro digestion (%).

6. The apparatus according to claim 5, characterized in that, The oat product samples to be tested include one or more of oats, oat bran, oat flour, and mixed oats.

7. The application of the apparatus according to any one of claims 5 to 7 in determining the GI value of oat products.

8. A method for improving the accuracy of in vitro prediction of the GI value of oat products, characterized in that, The glycemic index was calculated by substituting the β-glucan content, damaged starch content, median particle size, aleurone layer thickness, and 180-minute hydrolysis index of the oat product into the equation; the equation is as follows: GI=0.00035 × β-GL × DS × MP × AL × (HI-180) 2 +30.96 Wherein, GI value is the glycemic index of the oat being tested; β-GL is the β-glucan content of the oat being tested (g / 100g); DS is the damaged starch content of the oat being tested (%); MP is the median particle size of the oat being tested (μm); AL is the aleurone layer thickness of the oat being tested (μm); and HI-180 is the hydrolysis index of the oat being tested at 180 min (%).

9. The method according to claim 8, characterized in that, β-glucan content was determined using the enzymatic method according to GB 5009.289-2023; damaged starch content was determined according to AACC Method 76-31.01, the American Association of Cereal Chemists standard, "Determination of Damaged Starch (Maltose Method)"; median particle size was determined according to ISO 13320:2020 laser diffraction method; aleurone layer thickness was observed according to NY / T 2334-2013, "Methods for Identifying the Structure and Morphology of Cereal Grains"; the starch hydrolysis index from 0 to 180 minutes was determined based on in vitro simulated digestion experiments. The method for detecting the starch digestion and hydrolysis index from 0 to 180 min was the Englyst in vitro simulated digestion method.

10. The method according to claim 8, characterized in that, The oat product samples to be tested include one or more of oats, oat bran, oat flour, and mixed oats.